Evidence map›Paper›PMID 40741328›Full record

ArticleFrontiers in cell and developmental biology2025

The β-adrenergic receptor-SGK1 signaling pathway in brown adipocytes protects GOT1 from proteasomal degradation.

Chul-Hong Park, Minsung Park, J Jason Collier, Ji Suk Chang

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chul-Hong ParkLaboratory of Gene Regulation and Metabolism, Pennington Biomedical Research Center, Baton Rouge, LA, United States.
Minsung ParkLaboratory of Gene Regulation and Metabolism, Pennington Biomedical Research Center, Baton Rouge, LA, United States.
J Jason CollierIslet Biology and Inflammation, Pennington Biomedical Research Center, Baton Rouge, LA, United States.
Ji Suk ChangLaboratory of Gene Regulation and Metabolism, Pennington Biomedical Research Center, Baton Rouge, LA, United States.

Funding

Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Sujoy Ghosh · 2005 to 2026
$26.5M
The role of maternal obesity-driven inflammation and adverse pregnancy outcomes in a mouse model of preeclampsiaP20GM135002 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Jacqueline M Stephens · 2020 to 2026
$18.4M
SGK1 is a regulator of islet beta cell mass and secretory functionR01DK123183 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI COLLIER, JAMES JASON · 2020 to 2024
$1.8M
Regulation of brown fat fuel utilization by the malate-aspartate shuttleR01DK136536 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Ji Suk Chang · 2023 to 2026
$1.6M
NIDDK NIH HHS P30 DK072476NIDDK NIH HHS R01 DK123183NIDDK NIH HHS R01 DK136536NIGMS NIH HHS P20 GM135002
6 · The paper itself

Abstract

The malate-aspartate shuttle (MAS) is a key biochemical system that facilitates the transfer of reducing equivalents from the cytosol into mitochondria. It consists of two pairs of cytosolic and mitochondrial enzymes: glutamic-oxaloacetic transaminases (cGOT1, mGOT2) and malate dehydrogenases (cMDH1, mMDH2). We recently reported that cytosolic GOT1 is selectively elevated in brown adipocytes during cold exposure, while the expression of other MAS enzymes remains unchanged. Mechanistically, cold-induced activation of the β-adrenergic receptor (βAR)-cAMP-PKA signaling pathway promotes

Indexed as

beta-adrenergic receptorBrown adipose tissue (BAT)GOT1malate-aspartate shuttle (MAS)SGK1signaling/signaling pathwaysubiquitin-poteasome system

Identifiers

PMID40741328
PMCPMC12307365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.